Ilaprazole

Generic Name
Ilaprazole
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C19H18N4O2S
CAS Number
172152-36-2
Unique Ingredient Identifier
776Q6XX45J
Background

Ilaprazole has been investigated in Helicobacter Infections.

Indication

用于治疗十二指肠溃疡及反流性食管炎。

Associated Conditions
-
Associated Therapies
-
Clinical Trials
Related News

Study to Evaluate the Efficacy and Safety of Ilaprazole 10 mg in Prevention NSAIDs Associated Peptic Ulcer

First Posted Date
2024-02-29
Last Posted Date
2024-02-29
Lead Sponsor
Il-Yang Pharm. Co., Ltd.
Target Recruit Count
416
Registration Number
NCT06284876
Locations
🇰🇷

Chung Ang University Hospital, Seoul, Korea, Republic of

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Ilaprazole and Aceclofenac

First Posted Date
2022-09-28
Last Posted Date
2023-06-28
Lead Sponsor
Il-Yang Pharm. Co., Ltd.
Target Recruit Count
24
Registration Number
NCT05558150
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Study to Evaluate Pharmacokinetic Drug Interactions and Safety of Naproxen, Aceclofenac, Celecoxib and Ilaprazole

First Posted Date
2022-02-14
Last Posted Date
2023-06-28
Lead Sponsor
Il-Yang Pharm. Co., Ltd.
Target Recruit Count
72
Registration Number
NCT05237297
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

Phase III Study to Evaluate Safety and Efficacy of Ilaprazole in Patients With NERD

Phase 3
Completed
Conditions
Non-erosive Reflux Disease
Interventions
Drug: Ilaprazole
First Posted Date
2018-02-23
Last Posted Date
2021-01-05
Lead Sponsor
Il-Yang Pharm. Co., Ltd.
Target Recruit Count
277
Registration Number
NCT03444883
Locations
🇰🇷

Inje University Busan Paik Hospital, Busan, Busanjin-gu, Korea, Republic of

🇰🇷

Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, Jongno-gu, Korea, Republic of

🇰🇷

Seoul National University Hospital, Seoul, Jongno-gu, Korea, Republic of

and more 8 locations

IIaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

Phase 2
Completed
Conditions
Peptic Ulcer Hemorrhage
Interventions
Drug: Ilaprazole
Drug: omeprazole
First Posted Date
2017-12-05
Last Posted Date
2017-12-06
Lead Sponsor
Livzon Pharmaceutical Group Inc.
Target Recruit Count
180
Registration Number
NCT03362268

Ilaprazole for the Treatment and Prevention of Peptic Ulcer Bleeding in Chinese Patients

First Posted Date
2017-12-05
Last Posted Date
2017-12-06
Lead Sponsor
Livzon Pharmaceutical Group Inc.
Target Recruit Count
540
Registration Number
NCT03362281

Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment

First Posted Date
2017-05-03
Last Posted Date
2017-05-03
Lead Sponsor
Yanqing Li
Target Recruit Count
120
Registration Number
NCT03139253

Efficacy and Safety of 1-week Triple Therapy With Ilaprazole for the Eradication of Helicobacter Pylori

First Posted Date
2016-08-19
Last Posted Date
2016-08-19
Lead Sponsor
Livzon Pharmaceutical Group Inc.
Registration Number
NCT02873065

The Prospective Study on the Effect of Ilaprazole in Non-erosive Reflux Disease Patients; Focused on Histologic Findings and Inflammatory Biomarker

Phase 4
Completed
Conditions
Gastrointestinal Subepithelial Tumors
Interventions
Drug: Ilaprazole
First Posted Date
2016-01-28
Last Posted Date
2019-03-22
Lead Sponsor
Yonsei University
Target Recruit Count
20
Registration Number
NCT02666976
Locations
🇰🇷

Severance Hospital, Seoul, Korea, Republic of

The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients

First Posted Date
2016-01-07
Last Posted Date
2018-08-09
Lead Sponsor
Kyungpook National University Hospital
Target Recruit Count
50
Registration Number
NCT02648659
© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy